References
- Adami, J., Gäbel, H., Lindelöf, B., Ekström, K., Rydh, B., Glimelius, B., Ekbom, A., Adami, H. O., Granath, F. (2003). Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Brit. J. Cancer., 89 (7), 1221-1227.
- Afonso, L.A., Cordeiro, T. I., Carestiato, F. N., Ornellas, A. A., Alves, G., Cavalcanti, S. M. (2016). High-risk human papillomavirus infection of the foreskin in asymptomatic Mmen and patients with phimosis. J. Urol., Jan. 18, pii: S0022-5347 (16)00040-9.
- Albero, G., Castellsagué, X., Lin, H. Y., Fulp, W., Villa, L. L., Lazcano- Ponce, E., Papenfuss, M., Abrahamsen, M., Salmerón, J., Quiterio, M., Nyitray, A. G., Lu, B., Bosch, F. X., Giuliano, A. R. (2014). Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: The HPV infection in men (HIM) cohort study. BMC Infect. Dis., 14, 75.
- Amirian, E. S., Adler-Storthz, K., Scheurer, M. E. (2013). Associations between human herpesvirus-6, human papillomavirus and cervical cancer. Cancer Lett., 336 (1), 18-23.
- Brendle, S. A., Bywaters, S. M., Christensen, N. D. (2014). Pathogenesis of infection by human papillomavirus. Curr. Probl. Dermatol., 45, 47-57.
- Buell, J. F., Gross, T. G., Woodle, E. S. Malignancy after transplantation. (2005). Transplantation, 80 (2 Suppl), S254-64.
- Burd, E. M. Human papillomavirus and cervical cancer. (2003). Clin. Microbiol. Rev., 16 (1), 1-17.
- Cai, T., Perletti, G., Meacci, F., Magri, V., Verze, P., Palmieri, A., Mazzoli, S., Santi, R., Nesi, G., Mirone, V., Bartoletti, R. (2016). Natural history of human papillomavirus infection in non-vaccinated young males: Low clearance probability inhigh-risk genotypes. Eur. J. Clin. Microbiol. Infect. Dis., 35 (3), 463-469.
- Coscia, M. F., Monno, R., Ballini, A., Mirgaldi, R., Dipalma, G., Pettini, F., Cristallo, V., Inchingolo, F., Foti, C., de Vito, D. (2015) Human papilloma virus (HPV) genotypes prevalence in a region of South Italy (Apulia). Ann. Ist. Super. Sanita, 51 (3), 248-251.
- Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., Franceschi, S. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30 (Suppl 5), F12-23.
- Frazer, I. H. (2009). Interaction of human papillomaviruses with the host immune system: A well evolved relationship. Virology, 384 (2), 410-414.
- Genzer, O., El-Sayegh, S. E., Kleiner, M. J., Castellanos, M. R. (2012). Male human papillomavirus infection post-kidney transplant: An overlooked disease. Transplant Res., 1 (1), 21.
- Golijow, C. D., Pérez, L. O., Smith, J. S., Abba, M. C. (2005). Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina. J. Virol. Methods, 124 (1-2), 217-220.
- Grulich, A. E., van Leeuwen, M. T., Falster, M. O., Vajdic, C. M. (2007). Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet, 370 (9581), 59-67.
- Halpert, R., Fruchter, R. G., Sedlis, A., Butt, K., Boyce, J. G., Sillman, F. H. (1986). Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet. Gynecol., 68 (2), 251-258.
- Jacobs, M. V., de Roda Husman, A. M., van den Brule, A. J., Snijders, P. J., Meijer, C. J., Walboomers, J. M. (1995). Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol., 33 (4), 901-905.
- Leiros, G. J., Galliano, S. R., Sember, M. E., Kahn, T., Schwarz, E., Eiguchi, K. (2005). Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol., 5, 15.
- Li, X., Li, M., Yang, Y., Zhong, X., Feng, B., Xin, H., Li, Z., Jin, Q., Gao, L. (2016). Anal HPV/HIV co-infection among men who have sex with men: A cross-sectional survey from three cities in China. Sci. Rep., 6, 21368.
- Meeuwis, K. A., Hilbrands, L. B., IntHout, J., Slangen, B. F., Hendriks, I. M., Hinten, F., Christiaans, M. H., Quint, W. G., van de Kerkhof, P. C., Massuger, L. F., Hoitsma, A. J., van Rossum, M. M., Melchers, W. J., de Hullu, J. A. (2015). Cervicovaginal HPV infection in female renal transplant recipients: An observational, self-sampling based, cohort study. Amer. J. Transplant. 15 (3), 723-733.
- Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J., Meijer, C. J., International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J. Med. 348 (6), 518-527.
- Nyitray, A. G., Carvalho da Silva, R. J., Baggio, M. L., Smith, D., Abrahamsen, M., Papenfuss, M., Lin, H. Y., Quiterio, M., Salmerón, J., Lazcano-Ponce, E., Villa, L. L., Giuliano, A. R. (2011). Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: The HPV in men study. J. Infect. Dis., 204 (11), 1711-1722.
- Parkin, D. M. (2006). The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer., 118 (12), 3030-3044.
- Pathak, N., Dodds, J., Zamora, J., Khan, K. (2014). Accuracy of urinary human papillomavirus testing for presence of cervical HPV: Systematic review and meta-analysis. Brit. Med. J., 349, g5264.
- Scott, M., Nakagawa, M., Moscicki, A. B. (2001). Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol., 8 (2), 209-220.
- Shukla, S., Bharti, A. C., Mahata, S., Hussain, S., Kumar, R., Hedau, S., Das, B. C. (2009). Infection of human papillomaviruses in cancers of different human organ sites. Indian J. Med. Res., 130 (3), 222-233.
- Skiba, D., Mehlhorn, G., Fasching, P. A., Beckmann, M. W., Ackermann, S. (2006). Prognostic significance of serum antibodies to HPV-16 L1 virus- like particles in patients with invasive cervical cancer. Anticancer Res., 26(6C), 4921-4926.
- Stanley, M. (2008). Immunobiology of HPV and HPV vaccines. Gynecol. Oncol., 109 (2 Suppl), S15-21.
- Stanley, M. A., Sterling, J. C. (2014). Host responses to infection with human papillomavirus. Curr. Probl. Dermatol., 45, 58-74.
- Tillou, X., Doerfler, A. (2014). Urological tumors in renal transplantation. Minerva Urol. Nefrol., 66 (1), 57-67.
- Vandamme, A. M., Fransen, K., Debaisieux, L., Marissens, D., Sprecher, S., Vaira, D., Vandenbroucke, A. T., Verhofstede, C. (1995). Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J. Virol. Methods, 51 (2-3), 305-316.